Acute myeloid leukemia M1 has a very low cure rate of around 20% to 30% and is highly susceptible to relapse, with a relapse rate of around 70% within 5 years. Acute myeloid leukemia M1 is also known as acute granulocytic leukemia undifferentiated type. At present, the treatment of AML M1 is mainly based on chemotherapy and bone marrow transplantation. 1. Chemotherapy: chemotherapy regimens often use DA regimen, nearly 50% of patients may be in complete remission, but many patients may not be able to achieve remission after 2~3 courses of treatment, or some of them may experience relapse in the short term. Specific drugs include cytarabine and Zoerythromycin. 2. If the patient’s bone marrow match is successful, allogeneic hematopoietic stem cell transplantation can be completed as soon as possible, but the possibility of relapse still cannot be ruled out. Specific diagnosis and drug treatment should be carried out under the guidance of physicians.